English
Bulgarian
Chinese (Simplified)
Croatian
Czech
Danish
Dutch
Finnish
French
German
Greek
Hebrew
Hindi
Indonesian
Italian
Japanese
Korean
Macedonian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swedish
Thai
Turkish
Vietnamese
News
COVID-19 Vaccines for people with CML
January 2021 - The iCMLf is sharing a statement on COVID-19 vaccines for people with CML.
iCMLf CML and COVID-19 data first presented at ASH
December 2020 - The iCMLf CML and COVID-19 data was first presented during the session on Chronic Myeloid Leukemia: Therapy: CML: New and Beyond at the American Society of Hematology (ASH) Meeting in December.
649: COVID-19 in patients (pts) with chronic myeloid leukemia (CML): results from the International CML Foundation (iCMLf) CML and COVID-19 (CANDID) Study (Réa D et al.)
CML Highlights of ASH 2020 on December 16th at 13.00 CET
December 2020 - The next highlight in our series of iCMLf conversations is coming up. On December 16th Professor Giuseppe Saglio will host an iCMLf Conversation discussing the CML highlights of the 62nd Annual Meeting of the American Society of Haematology (ASH). Professors Susan Branford and Susanne Saußele will provide an overview of significant biological and clinical aspects presented during the meeting.
Don’t miss this opportunity and save the date for this live webinar.
CML Highlights of ASH 2020 – Biological and clinical overview
We cannot meet in person during ASH so we bring the CML highlights direct to you. Join leading CML experts as they discuss key aspects of the CML presentations.
- Chair: Professor Giuseppe Saglio, University of Turin (Italy)
- Biological overview: Professor Susan Branford,
SA Pathology/University of South Australia (Australia) - Clinical overview: Professor Susanne Saußele, University of Mannheim (Germany)
Date: December 16th at 13.00 Central European Time (CET)
Recognising extraordinary work in CML. Nominate now for the iCMLf Prizes
December 2020 - In these challenging times of the COVID-19 pandemic, it is more important than ever to direct all our efforts to provide the best possible care for patients with CML around the globe and to continue to work towards a cure for CML.
With this in mind, we continue with our tradition to recognise and reward personal contributions and outstanding achievements to our understanding of the biology of CML and to improving the management of patients with CML globally.
Since the first iCMLf Rowley Prize was awarded to Professor Brian Druker in 2009, we have honoured 26 scientists and clinicians with the three specific iCMLf Prizes.
Who would you like to see awarded the iCMLf prizes next year?
Highlights from the 22nd John Goldman E-Conference on CML 2020: Best abstract presentations and keynotes from iCMLf prize recipients
November 2020 - The virtual 22nd Annual John Goldman Conference on Chronic Myeloid Leukemia: Biology and Therapy was a great success with 577 participants from 57 countries. While we could not be together in person the e-conference was still an opportunity to share quality data, discussions, and debates.
Here are some highlights from the virtual meeting for you: You can view the keynote presentations from the 2020 iCMLf Prize recipients on the iCMLf website along with the two best scored abstracts.
Join Professor Hughes and Giora Sharf discussing TFR - November 12th at 13.00 CET
November 2020 - Please join us for our next iCMLf Conversation on CML. On November 12, Professor Timothy Hughes and Giora Sharf will provide an update on treatment-free remission (TFR) in chronic myeloid leukemia.
Update on treatment-free remission
– Perspectives from a physician and a patient representative
- Professor Timothy Hughes, SAHMRI/University of Adelaide (Australia)
- Giora Sharf, Co-Founder of CML Advocates Network and CML patient, Netanyah (Israel)
Date: November 12th at 13.00 Central European Time (CET)
